168 related articles for article (PubMed ID: 32998355)
1. Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System.
Cirri D; Schirmeister T; Seo EJ; Efferth T; Massai L; Messori L; Micale N
Molecules; 2020 Sep; 25(19):. PubMed ID: 32998355
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
[TBL] [Abstract][Full Text] [Related]
3. Selected cytotoxic gold compounds cause significant inhibition of 20S proteasome catalytic activities.
Micale N; Schirmeister T; Ettari R; Cinellu MA; Maiore L; Serratrice M; Gabbiani C; Massai L; Messori L
J Inorg Biochem; 2014 Dec; 141():79-82. PubMed ID: 25217719
[TBL] [Abstract][Full Text] [Related]
4. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
Cirri D; Geri A; Massai L; Mannelli M; Gamberi T; Magherini F; Becatti M; Gabbiani C; Pratesi A; Messori L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770719
[TBL] [Abstract][Full Text] [Related]
5. Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure-Activity Relationships.
Marzo T; Cirri D; Pollini S; Prato M; Fallani S; Cassetta MI; Novelli A; Rossolini GM; Messori L
ChemMedChem; 2018 Nov; 13(22):2448-2454. PubMed ID: 30252208
[TBL] [Abstract][Full Text] [Related]
6. New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway.
Tomasello MF; Nardon C; Lanza V; Di Natale G; Pettenuzzo N; Salmaso S; Milardi D; Caliceti P; Pappalardo G; Fregona D
Eur J Med Chem; 2017 Sep; 138():115-127. PubMed ID: 28651154
[TBL] [Abstract][Full Text] [Related]
7. Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.
Cirri D; Fabbrini MG; Massai L; Pillozzi S; Guerri A; Menconi A; Messori L; Marzo T; Pratesi A
Biometals; 2019 Dec; 32(6):939-948. PubMed ID: 31686259
[TBL] [Abstract][Full Text] [Related]
8. Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth.
Liu N; Li X; Huang H; Zhao C; Liao S; Yang C; Liu S; Song W; Lu X; Lan X; Chen X; Yi S; Xu L; Jiang L; Zhao C; Dong X; Zhou P; Li S; Wang S; Shi X; Dou PQ; Wang X; Liu J
Oncotarget; 2014 Jul; 5(14):5453-71. PubMed ID: 24977961
[TBL] [Abstract][Full Text] [Related]
9. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
Ndugire W; Raviranga NGH; Lao J; Ramström O; Yan M
Adv Healthc Mater; 2022 May; 11(9):e2101032. PubMed ID: 34350709
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic compounds from the fruits of Uapaca togoensis towards multifactorial drug-resistant cancer cells.
Kuete V; Sandjo LP; Seukep JA; Zeino M; Mbaveng AT; Ngadjui B; Efferth T
Planta Med; 2015 Jan; 81(1):32-8. PubMed ID: 25473921
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
Casini A; Messori L
Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T
Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532
[TBL] [Abstract][Full Text] [Related]
15. 8,8-bis-(Dihydroconiferyl)-diferulate displayed impressive cytotoxicity towards a panel of human and animal cancer cells.
Mbaveng AT; Damen F; Guefack MF; Tankeo SB; Abdelfatah S; Bitchagno GTM; Çelik İ; Kuete V; Efferth T
Phytomedicine; 2020 Apr; 70():153215. PubMed ID: 32388040
[TBL] [Abstract][Full Text] [Related]
16. The cellular and molecular pharmacology of auranofin and related gold complexes.
Crooke ST; Snyder RM
Scand J Rheumatol Suppl; 1986; 63():1-18. PubMed ID: 3474775
[TBL] [Abstract][Full Text] [Related]
17. Proteasome versus Thioredoxin Reductase Competition as Possible Biological Targets in Antitumor Mixed Thiolate-Dithiocarbamate Gold(III) Complexes.
Quero J; Cabello S; Fuertes T; Mármol I; Laplaza R; Polo V; Gimeno MC; Rodriguez-Yoldi MJ; Cerrada E
Inorg Chem; 2018 Sep; 57(17):10832-10845. PubMed ID: 30117739
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and anticancer activity in vitro evaluation of novel dicyanoaurate (I)-based complexes.
Karadağ A; Aydın A; Tekin Ş; Akbaş H; Şahin O; Sen F
Life Sci; 2020 Jun; 251():117635. PubMed ID: 32272179
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.
Jorda R; Dušek J; Řezníčková E; Pauk K; Magar PP; Imramovský A; Kryštof V
Eur J Med Chem; 2017 Jul; 135():142-158. PubMed ID: 28441582
[TBL] [Abstract][Full Text] [Related]
20. Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori.
Owings JP; McNair NN; Mui YF; Gustafsson TN; Holmgren A; Contel M; Goldberg JB; Mead JR
FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27279627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
